Registry of Lobbyists
Total Number of Communication Reports: 8
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Economic Development, Health
|
Organon Canada’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including biosimilar drugs and women’s health products, which are the company’s main sectors of activities.
|
Legislative Proposal, Bill or Resolution, Regulation
|
|
Health
|
Representations relating to the conditions under which biosimilar drugs are marketed and reimbursed in Canada. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current women’s health programs, the integration of biosimilar drugs into the drug plans administered by the Federal Government and to emphasize the importance that the federal government respect their respective jurisdiction with respect to the approval, marketing and reimbursement of Organon's products.
|
Policies or Program
|
|
Health
|
To actively promote the enhancement of publicly funded women’s health initiatives and programs, including the development of a Pan Canadian Women’s Health Strategy.
|
Policies or Program
|
|
Economic Development, Health
|
To actively promote the value of the pharmaceutical industry for Canada's economic health and well being, but more importantly for the health and well being of its citizens and to propose solutions for integrated health care in Canada.
|
Policies or Program
|
|
Economic Development, Health
|
To recommend policies that will attract increased investment in the pharmaceutical and well being industry, such as on policies, research programs and policies and the Innovation Agenda.
|
Policies or Program
|
At Organon, our mission is to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 established medicines and solutions across a range of areas including reproductive health, heart disease, breast cancer, allergies and asthma. In Canada, Organon is a leader in areas such as contraception, fertility, hormone therapy, biosimilars, cardiovascular and markets more than 30 pharmaceutical and biological products. Based in Montréal, Québec, Organon employs approximately 115 people across Canada
Michael Casia, President & Managing Director
Address:
300-16766 Route Transcanadienne
Kirkland, QC H9H 4M7
Canada
Telephone number:
800-387-1326
Organon Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking